Case Reports Acute Mesenteric Ischemia Due To Sma Thrombosis- A Case Reports

Ashwin P. Godbole; Asit V Patel; Palak K Naik; Yuvrajsinh Rathod

doi:10.48165/ijabms.2022.243818

Authors

Ashwin P. Godbole 3rd Year Resident, General Surgery Department Of General Surgery, Amcmet Medical College & L G General Hospital Maninagar Ahmedabad.pin 380008
Asit V Patel Professor & Head, General Surgery Department Of General Surgery, Amcmet Medical College & L G General Hospital Maninagar Ahmedabad.pin 380008
Palak K Naik 2nd Year Resident Department Of General Surgery, Amcmet Medical College & L G General Hospital Maninagar Ahmedabad.pin 380008
Yuvrajsinh Rathod 2nd Year Resident Department Of General Surgery, Amcmet Medical College & L G General Hospital Maninagar Ahmedabad.pin 380008

DOI:

https://doi.org/10.48165/ijabms.2022.243818

Keywords:

acute, Mesenteric Arteries, Thrombosis- A Case Reports

Abstract

INTRODUCTION:Acute mesenteric ischemia usually presents as abdominal pain that is out of proportion in relation to tenderness; persistent vomiting, bloody diarrhea and shock. Sloughing of intestinal mucosa takes 3 hours while infarction of entire bowel thickness occurs in 6 hours. [1]- [3] CECT abdomen with mesenteric angiography is investigation of choice. If patient has presented after 24-48 hours, gangrene might have already occurred, resection and anastomosis is done majority of cases with removal of vascular block under Doppler guidance or Injection of papaverine. Minimum bowel length required to be retained is 1.2 meters, otherwise the patient will have high mortality due to short bowel syndrome. [4]- [7] AIMS AND OBJECTIVES 1 ] To compare the surgical findings in various case scenarios having different presentations, patient factors and time of presentations with SMA thrombosis 2 ]To compare outcomes of surgical intervention in different case scenarios CONCLUSION:SMA thrombosis was seen in non-covid time as well. Hypercoagulable state which corresponds to raised d-dimer and FDP, the cases of mesenteric ischemia due to SMA thrombosis are seen more commonly in covid-19 era. This series draws to attention that timely diagnosis and appropriate surgery with resection and proper follow up with anti-coagulant the morbidity and mortality is averted. Acute mesenteric ischemia is commonly due to emboli (45-50%) rather than thrombosis (20-25%). Non occlusive disease (5-15%) can be due to various causes e.g., pancreatitis, sepsis, heart failure, etc. Early diagnosis is the key to successful management. Aggressive resuscitation, early revascularization with vascular intervention and exploratory laparotomy is done if evidence of peritonitis is present.[8]-[9] Postoperative fluid management due to short bowel syndrome and appropriate antibiotic coverage is necessary to revive the patient. Long term TPN support for patients with short bowel patients is necessary. They are candidates for intestinal transplantation if survived.

References

i. Oldenberg WA, Lau LL, Rodenberg, TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: a clinical review. Arch Intern Med. 2004; 164:1054-1062.

ii. Bjorck M, Acosta S, Lindberg F, Troeng T, Bergqvist D. Revascularization of the superior mesenteric artery after acute thromboembolic occlusion. Br J Surg. 2002;89:923-927.

iii.Endean ED, Barnes SL, Kwolek CJ, Minton TJ, Schwatz TH, Mentzer RW, Jr. Surgical management of thrombotic acute intestinal ischemia. Ann Surg. 2001;233:801-808.

iv.Acosta S, Ogren M, Sternby NH, Bergqvist D, Bjork M. Clinical implications of acute thromboembolic occlusion of the superior mesenteric artery: autopsy findings in 213 patients. AnnSurg. 2005; 24:516-522.

v.Bingol H, Zeybeck N, Cingoz F, Yilmaz AT, Tatar H, Sen D. Surgical therapy for acute mesenteric artery embolism. Am J Surg. 2004;188:68-70.

vi.Comerota AJ, Rao AK, Throm RC, et al. A prospective, randomized, blinded, and placebo controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularization. Regional and systemic effects. Ann Surg. 1993;218(4):534541.

vii.Schoots IG, Levi MM, Reekers JA, et al. Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol. 2005;16: 317-329.

viii.Landis MS, Rajan DK, Simons ME, et al. Percutaneous management of chronic mesenteric ischemia: outcomes after intervention. J Vasc Interv Radiol. 2005;16:13191325.

ix.Kasirajan K, O’Hara PJ, Gray BH, et al. Chronic mesenteric ischemia: open surgery versus percutaneous angioplasty and stenting. J Vasc Surg. 2001;33:63-71.

x.Kougias P, Panagiotis EF, Zhou W, Lin PH. Management of chronic mesenteric ischemia: the role of endovascular therapy. J Endovasc Ther. 2007;14(3):395-405.

xi.Wyers M, Powell R, Nolan B, Cronenwett J. Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia. J Vasc Surg. 2007;45:269-275.

xii.Klotz S, Vestring T, Rotker J, et al. Diagnosis and treatment of nonocclusive mesenteric ischemia after open heart surgery. Ann Thorac Surg. 2001; 72:1583-1586.

xiii. Trompeter M, Brazda T, Remy CT. Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol. 2002;12(5): 1179-1187.

xiv.Rhee RY, Gloviczki P, Mendonca CT, et al. Mesenteric venous thrombosis: still a lethal diseases in the 1990’s. J Vasc Surg. 1994;20:688-697.

xv.Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001;345:1683-1688. Abu-Daff S,

xvi. Abu-Daff N, Al-Shahed M. Mesenteric venous thrombosis and factors associated with mortality: a statistical analysis with five-year follow-up. J Gastrointest Surg. 2009;13:1245-1250.